Helen M. Thackray
Chief R&D Officer · BIOCRYST PHARMACEUTICALS INC
Individual
- 2024
- Dec 23, 2024
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Helen M. Thackray files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alane P. Barnes - $3.46M in BCRX purchases and sales in the last 12 months
- Theresa Heggie - $505K in BCRX purchases and sales in the last 12 months
- Amy E. McKee - $100K in BCRX purchases and sales in the last 12 months
- Machelle Sanders - $69K in BCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Helen M. Thackray?
Helen M. Thackray is a corporate insider, tracked as Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Helen M. Thackray last file a Form 4?
The most recent primary Form 4 on record is dated 23 December 2024, one of 2 filings going back to 2024.
